Work Here?
About Amgen
Industries
Biotechnology
Healthcare
Company Size
10,001+
Company Stage
IPO
Headquarters
Thousand Oaks, California
Founded
1980
Overview
Amgen develops medicines aimed at treating serious illnesses, focusing on biotechnology. The company researches, develops, and sells biologic therapies, which are medicines made from living organisms. These therapies target conditions like cancer, cardiovascular diseases, and autoimmune disorders. Amgen stands out from competitors by reinvesting a large portion of its earnings into research and development, ensuring a strong pipeline of new treatments. The goal of Amgen is to improve patient care and address critical health challenges through its innovative therapeutic solutions.
Simplify's Take
What believers are saying
- Amgen's investment in AI aligns with trends in biotechnology innovation.
- Institutional investments indicate strong market confidence in Amgen's growth.
- FTC clearance of the Horizon merger may ease future regulatory hurdles.
What critics are saying
- Competitors' AI-driven drug discovery could outpace Amgen's traditional R&D methods.
- FTC scrutiny of mergers may complicate Amgen's future growth strategy.
- Advancements in quantum technologies could pose a competitive threat to Amgen.
What makes Amgen unique
- Amgen focuses on biologic therapies derived from living organisms.
- The company has a strong pipeline of potential new therapies in development.
- Amgen's acquisition of Horizon Therapeutics enhances its rare disease portfolio.
Help us improve and share your feedback! Did you find this helpful?
Funding
Total Funding
$28514.4M
Above
Industry Average
Funded Over
2 Rounds
Company News
Factory Mutual Insurance Co. purchased a new position in Amgen Inc. (NASDAQ:AMGN - Free Report) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 53,500 shares of the medical research company's stock, valued at approxim
JPMorgan Chase has one of the world's most highly regarded specialist teams working on quantum technologies within the financial services industry and has been working with Quantinuum and its predecessor companies since 2020.
Northwest Quadrant Wealth Management LLC bought a new position in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 883 shares of the medical research company’s stock, valued at approximately $237,000. A number of other institutional investors […]
The Investor Relations website contains information about Horizon Therapeutics plc's business for stockholders, potential investors, and financial analysts.
The consent agreement struck between the FTC and Amgen and Horizon Therapeutics could have significant implications for ongoing and future M&A challenges, experts told BioSpace.
There are no jobs for Amgen right now.
Find jobs on Simplify and start your career today
People Also Viewed
Discover companies similar to Amgen
About Amgen
Industries
Biotechnology
Healthcare
Company Size
10,001+
Company Stage
IPO
Headquarters
Thousand Oaks, California
Founded
1980
There are no jobs for Amgen right now.
Find jobs on Simplify and start your career today
People Also Viewed
Discover companies similar to Amgen